SINOPHARM GROUP CO LTD (1099.HK)
25 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|54||2017||Executive Chairman of the Board and Deputy Secretary of Party Committee|
|45||2014||Non-Executive Vice Chairman of the Board|
|53||2013||Chief Financial Officer, Vice President|
- China, Hong Kong stocks skid as regulatory moves weigh on developers, banks
- Hong Kong stocks slip, fret over China March export drop
- China, Hong Kong stocks fall on soft exports data
- HK stocks rise for 4th session on China's deregulation pledge
- BRIEF-Sinopharm Group Co Expects Q1 Net Profit Attributable Down About 30%